Actively Recruiting

Phase Not Applicable
Age: 18Years - 40Years
All Genders
Healthy Volunteers
NCT04113759

Blood Flow Restriction Following Hip Arthroscopy

Led by Rush University Medical Center · Updated on 2025-12-05

56

Participants Needed

1

Research Sites

230 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will be a prospective randomized, double-blinded, placebo-controlled trial of patients undergoing primary hip arthroscopy for FAIS and/or labral pathology. All patients who sign the consent form will be enrolled in the study and randomized to one of the two treatment arms. Follow-up will take place at 1-month, 3-months, 6-months, and 1-year.

CONDITIONS

Official Title

Blood Flow Restriction Following Hip Arthroscopy

Who Can Participate

Age: 18Years - 40Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients aged 18 to 40 years
  • English-speaking
  • Clinical and MRI findings consistent with femoral acetabular impingement syndrome or labral pathology
  • Scheduled for primary hip arthroscopy
  • Provide written informed consent for study participation
Not Eligible

You will not qualify if you...

  • Younger than 18 or older than 40 years
  • Non-native English speaker
  • Previous surgery on the same side hip or knee or revision surgery
  • Unable to comply with follow-up clinic visits
  • Lacking decisional capacity
  • History of deep vein thrombosis, pulmonary embolism, clotting disorder, or hypercoagulable state
  • Pregnant or breastfeeding women; females of childbearing potential must use birth control during the study
  • Workers' compensation patients
  • Any significant health issues that pose risk or affect study completion
  • Psychiatric illness preventing understanding of the study or interfering with follow-up visits

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Rush University Medical Center

Chicago, Illinois, United States, 60612

Actively Recruiting

Loading map...

Research Team

C

Carla M. Edwards, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here